Last 16 quarters of trend data · Consumer Defensive · Education & Training Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
iHuman Inc.'s quarterly P/E stands at 0.2x, up 7.1% year-over-year.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 1.04 | 0.21 | 0.22 | 0.17 | 0.26 | 0.19 | 0.21 | 0.26 | 0.16 | 0.19 | 0.16 | 0.21 | 0.14 |
| — | +7.1% | +4.3% | -33.9% | +61.8% | +4.4% | +27.7% | +24.4% | +9.1% | — | — | — | — | |
| P/S Ratio | 0.11 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| — | +47.8% | +37.2% | -41.6% | -18.0% | -32.8% | -40.1% | +24.6% | +33.6% | +6.6% | -87.1% | — | — | |
| P/B Ratio | 0.11 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
| — | +29.0% | +15.6% | -45.9% | -24.7% | -42.0% | -51.3% | -3.9% | +10.7% | -25.2% | -85.7% | — | — | |
| P/FCF | 1.98 | — | — | — | — | — | — | — | — | — | — | 0.01 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | -11.77 | -7.26 | -12.53 | -18.27 | -7.54 | -10.26 | -10.65 | -11.85 | -5.80 | -5.34 | -3.72 | -6.05 | -5.24 |
| — | +29.2% | -17.6% | -54.2% | -30.0% | -92.0% | -186.3% | -95.8% | -10.8% | — | — | — | — | |
| EV / EBIT | -14.01 | -7.26 | -12.53 | -18.27 | -7.54 | -11.85 | -12.43 | -13.43 | -6.19 | -5.70 | -3.90 | -6.47 | -5.46 |
| — | +38.7% | -0.7% | -36.0% | -21.8% | -108.0% | -219.0% | -107.6% | -13.5% | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
iHuman Inc.'s operating margin was 9.7% in Q2 2025, down 0.5 pp QoQ and up 1.0 pp YoY. Gross margin contracted 3.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 67.8% | 68.3% | 67.2% | 68.4% | 70.5% | 71.5% | 71.2% | 71.4% | 70.9% | 70.0% | 69.4% | 70.4% |
| — | -3.9% | -4.5% | -5.5% | -4.1% | -0.5% | +2.2% | +2.5% | +1.4% | +2.2% | +0.1% | +1.3% | +2.8% | |
| Operating Margin | 7.8% | 9.7% | 10.3% | 6.4% | 8.6% | 8.8% | 7.4% | 8.7% | 15.4% | 17.0% | 21.4% | 15.0% | 15.3% |
| — | +11.2% | +38.1% | -26.7% | -44.0% | -48.4% | -65.2% | -41.8% | +0.8% | +481.4% | +163.5% | +73.9% | +96.6% | |
| Net Margin | 10.7% | 15.9% | 12.6% | 11.4% | 10.5% | 11.5% | 9.5% | 13.3% | 19.9% | 17.5% | 20.2% | 13.6% | 15.7% |
| — | +39.0% | +32.8% | -14.3% | -47.1% | -34.3% | -53.1% | -2.3% | +26.5% | +625.0% | +171.3% | +100.6% | +133.8% |
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.3% | 3.3% | 2.8% | 2.8% | 2.7% | 2.7% | 2.4% | 3.5% | 5.7% | 5.0% | 6.8% | 4.7% | 5.9% |
| — | +21.5% | +15.2% | -20.5% | -52.3% | -44.8% | -64.3% | -24.9% | -1.9% | +493.7% | +143.1% | -84.3% | -74.9% | |
| ROA | 6.9% | 2.4% | 1.9% | 1.9% | 1.8% | 1.8% | 1.6% | 2.3% | 3.8% | 3.2% | 4.1% | 2.8% | 3.4% |
| — | +30.7% | +20.5% | -19.8% | -52.0% | -43.2% | -61.2% | -16.1% | +11.1% | +531.1% | +154.5% | -9.9% | +39.8% | |
| ROIC | — | 13.7% | — | 17.3% | 11.3% | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
iHuman Inc.'s Debt/EBITDA ratio is 0.6x, down from 0.7x last quarter — comfortably within a safe range. The current ratio has improved 23.0% YoY to 3.55x, strengthening the short-term liquidity position.
| Metric | TTM | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| — | +301.1% | +301.6% | +285.1% | -42.0% | -27.7% | -27.6% | -65.6% | -75.7% | -92.2% | -49.7% | -96.0% | -96.5% | |
| Debt / EBITDA | 0.17 | 0.63 | 0.66 | 1.00 | 0.12 | 0.13 | 0.16 | 0.16 | 0.10 | 0.09 | 0.07 | 0.22 | 0.34 |
| — | +377.3% | +303.0% | +542.7% | +20.5% | +50.1% | +129.9% | -27.8% | -71.6% | — | — | -74.7% | -81.8% | |
| Current Ratio | 2.98 | 3.55 | 3.07 | 2.98 | 2.75 | 2.89 | 2.67 | 2.82 | 2.79 | 2.76 | 2.51 | 2.23 | 2.37 |
| — | +23.0% | +14.7% | +6.0% | -1.6% | +4.8% | +6.7% | +26.1% | +18.0% | +31.2% | -2.1% | +114.9% | +132.2% | |
| Quick Ratio | 2.93 | 3.49 | 3.02 | 2.93 | 2.71 | 2.85 | 2.64 | 2.78 | 2.76 | 2.73 | 2.47 | 2.20 | 2.33 |
| — | +22.7% | +14.6% | +5.4% | -1.8% | +4.5% | +6.5% | +26.5% | +18.6% | +33.3% | -1.6% | +120.7% | +145.0% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 16 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying IH stock.
iHuman Inc.'s current P/E is 1.0x. The average P/E over the last 4 quarters is 0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
iHuman Inc.'s current operating margin is 7.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking iHuman Inc.'s business trajectory between earnings reports.